Mayo Clinic News Network

News Resources

Items tagged as "Hematology"

Dr. Michael Camilleri-b-roll

Michael Camilleri, M.D., Mayo Clinic Gastroenterology and Hepatology b-roll

Created by Dave Hansen

Dr. Michael Camilleri, b-roll

Michael Camilleri, M.D., Mayo Clinic Gastroenterology and Hepatology b-roll

Created by Dave Hansen

Dr. Michael Camilleri-hydration/fiber (:49)

Michael Camilleri, M.D., Mayo Clinic Gastroenterology and Hepatology discusses issues surrounding constipation and the need for hydration and fiber. “People need to hydrate well…. …include fiber in the diet.” (:49)

Created by Dave Hansen

Dr. Michael Camilleri-Concerns (:33)

Michael Camilleri, M.D., Mayo Clinic Gastroenterology and Hepatology discusses issues surrounding constipation and how often people should expect to have a bowl movement. “People should be concerned if they go four or five days with out a bowel movement ….common system” (:33)

Created by Dave Hansen

Dr. Michael Camilleri-Issues (:34 )

Michael Camilleri, M.D., discusses issues surrounding constipation. “sometimes constipation can lead to severe abdominal pain and some patients experience so much pain in their abdomen they may to to the emergency room…. ….individual patient needs.” (:34 )

Created by Dave Hansen

Ansell what is PD1 (:37)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Ansell describes NHL and patients (:34)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Ansell describes clinical trial (:30)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Load More